查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617856

注射給藥市場：按設備類型、可用​​性、治療應用和最終用戶分類 - 2025-2030 年全球預測

Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Therapeutic Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

注射給藥市場2023年估值為9,722.5億美元，預計2024年將達到14,206億美元，複合年成長率為7.58%，到2030年將達到16,217億美元，預計將達到1,000萬美元。

注射給藥是指透過注射的方式將藥物注入體內，為口服或其他非侵入途徑無法有效代謝的藥物的遞送提供了重要手段。注射給藥的需求是因為其治療效果快、劑量準確，以及慢性病管理、免疫接種和緊急情況下的必要性。典型應用包括癌症、糖尿病、心血管疾病和疫苗，最終用途包括醫療機構、居家照護環境和專科診所。該市場的成長是由生技藥品的進步、慢性病盛行率的增加以及智慧型設備和自行注射設備等技術創新所推動的。此外，生技藥品和生物相似藥的興起增加了對新型有效注射給藥系統的需求。

主要市場統計
基準年[2023] 9722.5億美元
預計年份 [2024] 1,420,060 百萬美元
預測年份 [2030] 1,621,710 百萬美元
複合年成長率（%） 7.58%

然而，重大挑戰仍然存在，包括高昂的開發成本、嚴格的法律規範、患者依從性問題以及與針頭系統相關的安全風險。機會在於開發利用無針技術和物聯網來提高依從性和患者管理的連網型設備。預填充式注射器和自動注射器的普及、穿戴式注射器的進步以及數位健康技術的整合預計將推動市場擴張。為了利用這些機會，公司應該投資以患者為中心的設計研發，並與科技公司合作以增強藥物輸送體驗。產業也應專注於克服可能抑製成長的限制，例如製造複雜性和生物有效性問題。此外，創新領域包括微針貼片、生物分解性聚合物和緩釋性輸送系統的開發，預計將顛覆傳統模式。該市場的特點是其動態性，擴大轉向個人化醫療，並且需要不斷監控監管和技術環境以保持競爭力。

市場動態：揭示快速發展的注射給藥市場的關鍵市場洞察

供需的動態交互作用正在改變注射給藥市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 針技術的技術進步
    • 慢性病增加
    • 世界老年人口顯著成長
  • 市場限制因素
    • 開發注射給藥解決方案的成本高昂
  • 市場機會
    • 智慧注射裝置的開發
    • 對自我管理設備的需求增加
  • 市場挑戰
    • 患者對針頭的依從性差且缺乏注射設備使用訓練

波特五力：駕馭注射給藥市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解注射給藥市場的外部影響

外部宏觀環境因素在塑造注射給藥市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解注射給藥市場的競爭格局

對注射給藥市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣注射給藥市場供應商績效評估

FPNV 定位矩陣是評估注射給藥市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了注射給藥市場的成功之路

注射給藥市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 針技術的技術進步
      • 慢性病增加
      • 世界各地的老年人口正在迅速增加。
    • 抑制因素
      • 注射給藥解決方案的開發成本較高
    • 機會
      • 智慧注射裝置的開發
      • 對自我管理設備的需求增加
    • 任務
      • 患者針頭依從性差且缺乏注射設備使用訓練
  • 市場區隔分析
    • 設備類型：由於易於使用，自行注射設備越來越受青睞
    • 最終用戶：考慮安全性和便攜性，考慮在居家照護環境中的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依設備類型分類的注射給藥市場

  • 傳統注射裝置
  • 自注射器
    • 自動注射器
    • 無針注射器
    • 筆式注射器
    • 穿戴式注射器

第7章注射給藥市場：依可用性

  • 一次性的
  • 可重複使用的

第8章依治療應用分類的注射給藥市場

  • 自體免疫疾病
  • 癌症
  • 慢性病
  • 荷爾蒙療法
  • 感染疾病

第9章注射給藥市場：依最終用戶分類

  • 家庭護理設置
  • 醫院/診所

第10章美洲注射給藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太注射給藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲注射給藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 斯蒂瓦那托集團推出 Vertiva，一種創新的內部給藥系統，旨在改善患者照護和永續性
    • Altaviz 推出 AltaVISC，一種創新的自動注射器平台，可提高藥物輸送效率
    • UDENYCA 自動注射器的推出提高了患者的可及性和管理效率
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Antares Pharma by Halozyme Therapeutics
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Emperra GmbH
  • Enable Injections LLC
  • F. Hoffman-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PlC
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Ravimed Sp. z oo
  • Recipharm AB
  • Sanofi SA
  • SiO2 Medical Products
  • Stevanato Group
  • Tandem Diabetes Care
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
Product Code: MRR-CB04E0565350

The Injectable Drug Delivery Market was valued at USD 972.25 billion in 2023, expected to reach USD 1,042.06 billion in 2024, and is projected to grow at a CAGR of 7.58%, to USD 1,621.71 billion by 2030.

Injectable drug delivery refers to the administration of medications into the body through injections, offering a critical avenue for delivering drugs that cannot be effectively metabolized through oral or other non-invasive routes. The necessity for injectable drug delivery stems from its ability to provide rapid onset of therapeutic action, precision in dosage administration, and is vital for managing chronic diseases, vaccinations, and emergency situations. Key applications span a wide range including oncology, diabetes, cardiovascular diseases, and vaccines, with end-use diverging across healthcare facilities, homecare settings, and specialized clinics. Growth in this market is propelled by advancements in biologics, increasing prevalence of chronic diseases, and technological innovations such as smart and self-injecting devices. Additionally, the rise of biologics and biosimilars is increasing demand for novel and effective injectable delivery systems.

KEY MARKET STATISTICS
Base Year [2023] USD 972.25 billion
Estimated Year [2024] USD 1,042.06 billion
Forecast Year [2030] USD 1,621.71 billion
CAGR (%) 7.58%

However, substantial challenges persist, including the high cost of development, stringent regulatory frameworks, and issues around patient compliance and safety risks associated with needle-based systems. Opportunities lie in the development of needle-free technologies and connected devices powered by IoT that improve adherence and patient management. Market expansion is likely influenced by the increasing popularity of pre-filled syringes and auto-injectors, advancements in wearable injectors, and the integration of digital health technologies. To capitalize on these opportunities, companies should invest in R&D for patient-centric designs and collaborate with technology firms to enhance the drug delivery experience. Industries should also focus on overcoming limitations such as manufacturing complexities and bioavailability issues that may impede growth. Furthermore, innovation areas include the development of microneedle patches, biodegradable polymers, and sustained-release delivery systems that promise to disrupt traditional paradigms. The market is characterized by its dynamic nature, with an increasing shift towards personalized medicine, which mandates constant surveillance of regulatory and technological landscapes to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Injectable Drug Delivery Market

The Injectable Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Technological advancements in needle technology
    • Increasing prevalence of chronic diseases
    • Significant rise in elderly population worldwide
  • Market Restraints
    • High development costs of injectable drug delivery solutions
  • Market Opportunities
    • Development of smart injection devices
    • Increasing demand for self-administration devices
  • Market Challenges
    • Low patient compliance of needles and lack of training in using injectable devices

Porter's Five Forces: A Strategic Tool for Navigating the Injectable Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Injectable Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Injectable Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Injectable Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Injectable Drug Delivery Market

A detailed market share analysis in the Injectable Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Injectable Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Injectable Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Injectable Drug Delivery Market

A strategic analysis of the Injectable Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injectable Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Antares Pharma by Halozyme Therapeutics, Becton, Dickinson and Company, Eli Lilly and Company, Emperra GmbH, Enable Injections LLC, F. Hoffman - La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PlC, Novo Nordisk A/S, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SiO2 Medical Products, Stevanato Group, Tandem Diabetes Care, West Pharmaceutical Services, Inc., and Wilhelm Haselmeier GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Injectable Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Conventional Injection Devices and Self-injection Devices. The Self-injection Devices is further studied across Autoinjectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors.
  • Based on Usability, market is studied across Disposable and Reusable.
  • Based on Therapeutic Application, market is studied across Autoimmune Diseases, Cancer, Chronic Diseases, Hormonal Therapies, and Infectious Diseases.
  • Based on End-user, market is studied across Home Care Settings and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Technological advancements in needle technology
      • 5.1.1.2. Increasing prevalence of chronic diseases
      • 5.1.1.3. Significant rise in elderly population worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High development costs of injectable drug delivery solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of smart injection devices
      • 5.1.3.2. Increasing demand for self-administration devices
    • 5.1.4. Challenges
      • 5.1.4.1. Low patient compliance of needles and lack of training in using injectable devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Increasing preference for self-injection devices due to ease of use
    • 5.2.2. End-user: Exploring applications in home care settings due to safety and portability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Injectable Drug Delivery Market, by Device Type

  • 6.1. Introduction
  • 6.2. Conventional Injection Devices
  • 6.3. Self-injection Devices
    • 6.3.1. Autoinjectors
    • 6.3.2. Needle-free Injectors
    • 6.3.3. Pen Injectors
    • 6.3.4. Wearable Injectors

7. Injectable Drug Delivery Market, by Usability

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Injectable Drug Delivery Market, by Therapeutic Application

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Chronic Diseases
  • 8.5. Hormonal Therapies
  • 8.6. Infectious Diseases

9. Injectable Drug Delivery Market, by End-user

  • 9.1. Introduction
  • 9.2. Home Care Settings
  • 9.3. Hospitals & Clinics

10. Americas Injectable Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Injectable Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Injectable Drug Delivery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Stevanato Group Launches Vertiva, An Innovative On-Body Drug Delivery System for Enhanced Patient Care and Sustainability
    • 13.3.2. Altaviz Introduces AltaVISC, A Revolutionary Auto-injector Platform Enhancing Drug Delivery Efficiency
    • 13.3.3. Launch of UDENYCA Autoinjector Enhances Patient Accessibility and Administration Efficiency
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Antares Pharma by Halozyme Therapeutics
  • 3. Becton, Dickinson and Company
  • 4. Eli Lilly and Company
  • 5. Emperra GmbH
  • 6. Enable Injections LLC
  • 7. F. Hoffman - La Roche Ltd.
  • 8. Insulet Corporation
  • 9. Johnson & Johnson Services, Inc.
  • 10. Medtronic PlC
  • 11. Novo Nordisk A/S
  • 12. Pfizer, Inc.
  • 13. Ravimed Sp. z o.o.
  • 14. Recipharm AB
  • 15. Sanofi S.A.
  • 16. SiO2 Medical Products
  • 17. Stevanato Group
  • 18. Tandem Diabetes Care
  • 19. West Pharmaceutical Services, Inc.
  • 20. Wilhelm Haselmeier GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. INJECTABLE DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. INJECTABLE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INJECTABLE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INJECTABLE DRUG DELIVERY MARKET DYNAMICS
  • TABLE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023